IBDEI3F1 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,57457,1,3,0)
 ;;=3^Candidiasis of Vulva & Vagina
 ;;^UTILITY(U,$J,358.3,57457,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,57457,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,57458,0)
 ;;=A59.01^^267^2878^57
 ;;^UTILITY(U,$J,358.3,57458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57458,1,3,0)
 ;;=3^Trichomonal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,57458,1,4,0)
 ;;=4^A59.01
 ;;^UTILITY(U,$J,358.3,57458,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,57459,0)
 ;;=D25.9^^267^2878^40
 ;;^UTILITY(U,$J,358.3,57459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57459,1,3,0)
 ;;=3^Leiomyoma of Uterus,Unspec
 ;;^UTILITY(U,$J,358.3,57459,1,4,0)
 ;;=4^D25.9
 ;;^UTILITY(U,$J,358.3,57459,2)
 ;;=^5002081
 ;;^UTILITY(U,$J,358.3,57460,0)
 ;;=D06.9^^267^2878^10
 ;;^UTILITY(U,$J,358.3,57460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57460,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Unspec
 ;;^UTILITY(U,$J,358.3,57460,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,57460,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,57461,0)
 ;;=D06.0^^267^2878^11
 ;;^UTILITY(U,$J,358.3,57461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57461,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,57461,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,57461,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,57462,0)
 ;;=D06.1^^267^2878^12
 ;;^UTILITY(U,$J,358.3,57462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57462,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,57462,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,57462,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,57463,0)
 ;;=N60.11^^267^2878^24
 ;;^UTILITY(U,$J,358.3,57463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57463,1,3,0)
 ;;=3^Diffuse Cystic Mastopathy,Right Breast
 ;;^UTILITY(U,$J,358.3,57463,1,4,0)
 ;;=4^N60.11
 ;;^UTILITY(U,$J,358.3,57463,2)
 ;;=^5015773
 ;;^UTILITY(U,$J,358.3,57464,0)
 ;;=N60.12^^267^2878^23
 ;;^UTILITY(U,$J,358.3,57464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57464,1,3,0)
 ;;=3^Diffuse Cystic Mastopathy,Left Breast
 ;;^UTILITY(U,$J,358.3,57464,1,4,0)
 ;;=4^N60.12
 ;;^UTILITY(U,$J,358.3,57464,2)
 ;;=^5015774
 ;;^UTILITY(U,$J,358.3,57465,0)
 ;;=N63.^^267^2878^41
 ;;^UTILITY(U,$J,358.3,57465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57465,1,3,0)
 ;;=3^Lump in Breast,Unspec
 ;;^UTILITY(U,$J,358.3,57465,1,4,0)
 ;;=4^N63.
 ;;^UTILITY(U,$J,358.3,57465,2)
 ;;=^5015791
 ;;^UTILITY(U,$J,358.3,57466,0)
 ;;=N73.9^^267^2878^31
 ;;^UTILITY(U,$J,358.3,57466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57466,1,3,0)
 ;;=3^Female Pelvic Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,57466,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,57466,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,57467,0)
 ;;=N72.^^267^2878^37
 ;;^UTILITY(U,$J,358.3,57467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57467,1,3,0)
 ;;=3^Inflammatory Disease of Cervix Uteri
 ;;^UTILITY(U,$J,358.3,57467,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,57467,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,57468,0)
 ;;=N76.0^^267^2878^62
 ;;^UTILITY(U,$J,358.3,57468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57468,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,57468,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,57468,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,57469,0)
 ;;=N76.1^^267^2878^63
 ;;^UTILITY(U,$J,358.3,57469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57469,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,57469,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,57469,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,57470,0)
 ;;=N81.3^^267^2878^59
 ;;^UTILITY(U,$J,358.3,57470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57470,1,3,0)
 ;;=3^Uterovaginal Prolapse,Complete
 
--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3F1   4012     printed  Sep 23, 2025@20:23:33                                                                                                                                                                                                    Page 2
IBDEI3F1  ; ; 19-NOV-2015
 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 +2        if 'DIFQR(358.3)
               QUIT 
           FOR I=1:2
               SET X=$TEXT(Q+I)
               if X=""
                   QUIT 
               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
               SET X=$EXTRACT(X,4,999)
               if $ASCII(Y)=126
                   SET I=I+1
                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
               if $ASCII(Y)=61
                   SET Y=$EXTRACT(Y,2,999)
               XECUTE NO
              IF '$TEST
                   SET @X=Y
Q          QUIT 
 +1       ;;^UTILITY(U,$J,358.3,57457,1,3,0)
 +2       ;;=3^Candidiasis of Vulva & Vagina
 +3       ;;^UTILITY(U,$J,358.3,57457,1,4,0)
 +4       ;;=4^B37.3
 +5       ;;^UTILITY(U,$J,358.3,57457,2)
 +6       ;;=^5000615
 +7       ;;^UTILITY(U,$J,358.3,57458,0)
 +8       ;;=A59.01^^267^2878^57
 +9       ;;^UTILITY(U,$J,358.3,57458,1,0)
 +10      ;;=^358.31IA^4^2
 +11      ;;^UTILITY(U,$J,358.3,57458,1,3,0)
 +12      ;;=3^Trichomonal Vulvovaginitis
 +13      ;;^UTILITY(U,$J,358.3,57458,1,4,0)
 +14      ;;=4^A59.01
 +15      ;;^UTILITY(U,$J,358.3,57458,2)
 +16      ;;=^121763
 +17      ;;^UTILITY(U,$J,358.3,57459,0)
 +18      ;;=D25.9^^267^2878^40
 +19      ;;^UTILITY(U,$J,358.3,57459,1,0)
 +20      ;;=^358.31IA^4^2
 +21      ;;^UTILITY(U,$J,358.3,57459,1,3,0)
 +22      ;;=3^Leiomyoma of Uterus,Unspec
 +23      ;;^UTILITY(U,$J,358.3,57459,1,4,0)
 +24      ;;=4^D25.9
 +25      ;;^UTILITY(U,$J,358.3,57459,2)
 +26      ;;=^5002081
 +27      ;;^UTILITY(U,$J,358.3,57460,0)
 +28      ;;=D06.9^^267^2878^10
 +29      ;;^UTILITY(U,$J,358.3,57460,1,0)
 +30      ;;=^358.31IA^4^2
 +31      ;;^UTILITY(U,$J,358.3,57460,1,3,0)
 +32      ;;=3^Carcinoma in Situ of Cervix,Unspec
 +33      ;;^UTILITY(U,$J,358.3,57460,1,4,0)
 +34      ;;=4^D06.9
 +35      ;;^UTILITY(U,$J,358.3,57460,2)
 +36      ;;=^5001941
 +37      ;;^UTILITY(U,$J,358.3,57461,0)
 +38      ;;=D06.0^^267^2878^11
 +39      ;;^UTILITY(U,$J,358.3,57461,1,0)
 +40      ;;=^358.31IA^4^2
 +41      ;;^UTILITY(U,$J,358.3,57461,1,3,0)
 +42      ;;=3^Carcinoma in Situ of Endocervix
 +43      ;;^UTILITY(U,$J,358.3,57461,1,4,0)
 +44      ;;=4^D06.0
 +45      ;;^UTILITY(U,$J,358.3,57461,2)
 +46      ;;=^5001938
 +47      ;;^UTILITY(U,$J,358.3,57462,0)
 +48      ;;=D06.1^^267^2878^12
 +49      ;;^UTILITY(U,$J,358.3,57462,1,0)
 +50      ;;=^358.31IA^4^2
 +51      ;;^UTILITY(U,$J,358.3,57462,1,3,0)
 +52      ;;=3^Carcinoma in Situ of Exocervix
 +53      ;;^UTILITY(U,$J,358.3,57462,1,4,0)
 +54      ;;=4^D06.1
 +55      ;;^UTILITY(U,$J,358.3,57462,2)
 +56      ;;=^5001939
 +57      ;;^UTILITY(U,$J,358.3,57463,0)
 +58      ;;=N60.11^^267^2878^24
 +59      ;;^UTILITY(U,$J,358.3,57463,1,0)
 +60      ;;=^358.31IA^4^2
 +61      ;;^UTILITY(U,$J,358.3,57463,1,3,0)
 +62      ;;=3^Diffuse Cystic Mastopathy,Right Breast
 +63      ;;^UTILITY(U,$J,358.3,57463,1,4,0)
 +64      ;;=4^N60.11
 +65      ;;^UTILITY(U,$J,358.3,57463,2)
 +66      ;;=^5015773
 +67      ;;^UTILITY(U,$J,358.3,57464,0)
 +68      ;;=N60.12^^267^2878^23
 +69      ;;^UTILITY(U,$J,358.3,57464,1,0)
 +70      ;;=^358.31IA^4^2
 +71      ;;^UTILITY(U,$J,358.3,57464,1,3,0)
 +72      ;;=3^Diffuse Cystic Mastopathy,Left Breast
 +73      ;;^UTILITY(U,$J,358.3,57464,1,4,0)
 +74      ;;=4^N60.12
 +75      ;;^UTILITY(U,$J,358.3,57464,2)
 +76      ;;=^5015774
 +77      ;;^UTILITY(U,$J,358.3,57465,0)
 +78      ;;=N63.^^267^2878^41
 +79      ;;^UTILITY(U,$J,358.3,57465,1,0)
 +80      ;;=^358.31IA^4^2
 +81      ;;^UTILITY(U,$J,358.3,57465,1,3,0)
 +82      ;;=3^Lump in Breast,Unspec
 +83      ;;^UTILITY(U,$J,358.3,57465,1,4,0)
 +84      ;;=4^N63.
 +85      ;;^UTILITY(U,$J,358.3,57465,2)
 +86      ;;=^5015791
 +87      ;;^UTILITY(U,$J,358.3,57466,0)
 +88      ;;=N73.9^^267^2878^31
 +89      ;;^UTILITY(U,$J,358.3,57466,1,0)
 +90      ;;=^358.31IA^4^2
 +91      ;;^UTILITY(U,$J,358.3,57466,1,3,0)
 +92      ;;=3^Female Pelvic Inflammatory Disease,Unspec
 +93      ;;^UTILITY(U,$J,358.3,57466,1,4,0)
 +94      ;;=4^N73.9
 +95      ;;^UTILITY(U,$J,358.3,57466,2)
 +96      ;;=^5015820
 +97      ;;^UTILITY(U,$J,358.3,57467,0)
 +98      ;;=N72.^^267^2878^37
 +99      ;;^UTILITY(U,$J,358.3,57467,1,0)
 +100     ;;=^358.31IA^4^2
 +101     ;;^UTILITY(U,$J,358.3,57467,1,3,0)
 +102     ;;=3^Inflammatory Disease of Cervix Uteri
 +103     ;;^UTILITY(U,$J,358.3,57467,1,4,0)
 +104     ;;=4^N72.
 +105     ;;^UTILITY(U,$J,358.3,57467,2)
 +106     ;;=^5015812
 +107     ;;^UTILITY(U,$J,358.3,57468,0)
 +108     ;;=N76.0^^267^2878^62
 +109     ;;^UTILITY(U,$J,358.3,57468,1,0)
 +110     ;;=^358.31IA^4^2
 +111     ;;^UTILITY(U,$J,358.3,57468,1,3,0)
 +112     ;;=3^Vaginitis,Acute
 +113     ;;^UTILITY(U,$J,358.3,57468,1,4,0)
 +114     ;;=4^N76.0
 +115     ;;^UTILITY(U,$J,358.3,57468,2)
 +116     ;;=^5015826
 +117     ;;^UTILITY(U,$J,358.3,57469,0)
 +118     ;;=N76.1^^267^2878^63
 +119     ;;^UTILITY(U,$J,358.3,57469,1,0)
 +120     ;;=^358.31IA^4^2
 +121     ;;^UTILITY(U,$J,358.3,57469,1,3,0)
 +122     ;;=3^Vaginitis,Subacute & Chronic
 +123     ;;^UTILITY(U,$J,358.3,57469,1,4,0)
 +124     ;;=4^N76.1
 +125     ;;^UTILITY(U,$J,358.3,57469,2)
 +126     ;;=^5015827
 +127     ;;^UTILITY(U,$J,358.3,57470,0)
 +128     ;;=N81.3^^267^2878^59
 +129     ;;^UTILITY(U,$J,358.3,57470,1,0)
 +130     ;;=^358.31IA^4^2
 +131     ;;^UTILITY(U,$J,358.3,57470,1,3,0)
 +132     ;;=3^Uterovaginal Prolapse,Complete